UnissResearch

Logo Universitàegli studi di Sassari
titoli, abstracts, parole chiave >>>
Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines

Marverti, Gaetano and Ligabue, Alessio and Guerrieri, Davide and Paglietti, Giuseppe and Piras, Sandra and Costi, Maria Paola and Farina, Davide Salvatore Francesco and Frassineti, Chiara and Monti, Maria Giuseppina and Moruzzi, Maria Stella (2010) Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Gynecologic Oncology, Vol. 117 (2), p. 202-210. eISSN 1095-6859. Article.

Full text not available from this repository.

DOI: 10.1016/j.ygyno.2009.11.030

Abstract

Objective
Polyamines have been shown to play a role in the growth and survival of several solid tumors, including ovarian cancer. Intracellular polyamine depletion by the inhibition of biosynthesis enzymes or by the induction of the catabolic pathway leads to antiproliferative effects in many different tumor cell lines. Recent studies showed that the thymidylate synthase inhibitor 5-fluorouracil (5-FU) affects polyamine metabolism in colon carcinoma cells through the induction of the key catabolic enzyme spermidine/spermine N1-acetyltransferase (SSAT).
Methods
We therefore examined whether combinations of novel folate cycle inhibitors with quinoxaline structure and drugs that specifically target polyamine metabolism, such as diethylderivatives of norspermine (DENSPM) or spermine (BESpm), have synergistic effect in killing cisplatin-sensitive and drug-resistant daughter human ovarian cell lines.
Results
Our results showed that simultaneous drug combination or quinoxaline pre-treatment synergistically increased SSAT expression, depleted polyamines, increased reactive oxygen species production, and produced synergistic tumor cell killing in both cell lines. Of note, this combined therapy increased the chemosensitivity of cisplatin-resistant cells and cross-resistant to the polyamine analogues. On the contrary, some pre-treatment regimens of Spm analogues were antagonistic.
Conclusions
These results show that SSAT plays an important role in novel folate cycle inhibitors effects and suggest that their combination with analogues has potential for development as therapy for ovarian carcinoma based on SSAT modulation.

Item Type:Article
ID Code:5665
Status:Published
Refereed:Yes
Uncontrolled Keywords:Quinoxalines, folate cycle inhibitors, SSAT, cisplatin, polyamine analogues
Subjects:Area 03 - Scienze chimiche > CHIM/08 Chimica farmaceutica
Divisions:001 Università di Sassari > 01 Dipartimenti > Farmaco, chimico, tossicologico
Publisher:Academic Press / Elsevier
eISSN:1095-6859
Copyright Holders:© 2009 Elsevier
Deposited On:08 Mar 2011 11:45

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page